Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with (90)Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI

The purpose of this study was to determine if parameters derived from diffusion-weighted (DW-) and dynamic contrast-enhanced (DCE-) magnetic resonance imaging (MRI) can help to assess early response to peptide receptor radionuclide therapy (PRRT) with (90)Y-DOTATOC in neuroendocrine hepatic metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Weikert, Thomas, Maas, Ole Christopher, Haas, Tanja, Klarhöfer, Markus, Bremerich, Jens, Forrer, Flavio, Sauter, Alexander Walter, Sommer, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877975/
https://www.ncbi.nlm.nih.gov/pubmed/31787860
http://dx.doi.org/10.1155/2019/1517208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877975/
https://www.ncbi.nlm.nih.gov/pubmed/31787860
http://dx.doi.org/10.1155/2019/1517208

Ejemplares similares